HEADER PROTEIN BINDING 12-NOV-09 3AAA TITLE CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH V-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: F-ACTIN-CAPPING PROTEIN SUBUNIT ALPHA-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CAPZ 36/32, BETA-ACTININ SUBUNIT I; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: F-ACTIN-CAPPING PROTEIN SUBUNIT BETA ISOFORMS 1 AND 2; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: CAPZ B1 AND B2, CAPZ 36/32, BETA-ACTININ SUBUNIT II; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: MYOTROPHIN; COMPND 13 CHAIN: C; COMPND 14 SYNONYM: PROTEIN V-1; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: CAPZA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PETDUET1; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 13 ORGANISM_COMMON: CHICKEN; SOURCE 14 ORGANISM_TAXID: 9031; SOURCE 15 GENE: CAPZB; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 (DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PETDUET1; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 GENE: MTPN; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 28 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 (DE3); SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PGEX6P1 KEYWDS ACTIN CAPPING PROTEIN, BARBED END CAPPING, INHIBITION, PROTEIN KEYWDS 2 BINDING, ACTIN CAPPING, ACTIN-BINDING, CYTOSKELETON, ANK REPEAT EXPDTA X-RAY DIFFRACTION AUTHOR S.TAKEDA,S.MINAKATA,A.NARITA,M.KITAZAWA,T.YAMAKUNI,Y.MAEDA,Y.NITANAI REVDAT 2 01-NOV-23 3AAA 1 REMARK SEQADV REVDAT 1 04-AUG-10 3AAA 0 JRNL AUTH S.TAKEDA,S.MINAKATA,R.KOIKE,I.KAWAHATA,A.NARITA,M.KITAZAWA, JRNL AUTH 2 M.OTA,T.YAMAKUNI,Y.MAEDA,Y.NITANAI JRNL TITL TWO DISTINCT MECHANISMS FOR ACTIN CAPPING PROTEIN JRNL TITL 2 REGULATION--STERIC AND ALLOSTERIC INHIBITION JRNL REF PLOS BIOL. V. 8 00416 2010 JRNL REFN ISSN 1544-9173 JRNL PMID 20625546 JRNL DOI 10.1371/JOURNAL.PBIO.1000416 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 36744 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1941 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.21 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2640 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.1770 REMARK 3 BIN FREE R VALUE SET COUNT : 139 REMARK 3 BIN FREE R VALUE : 0.2720 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5034 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 8 REMARK 3 SOLVENT ATOMS : 354 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.07000 REMARK 3 B22 (A**2) : 0.05000 REMARK 3 B33 (A**2) : -0.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.248 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.204 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.813 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5140 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6953 ; 1.419 ; 1.957 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 631 ; 5.490 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 254 ;38.546 ;25.118 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 911 ;14.446 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;15.767 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 763 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3911 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3154 ; 0.956 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5085 ; 1.831 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1986 ; 2.773 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1868 ; 4.591 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3AAA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-NOV-09. REMARK 100 THE DEPOSITION ID IS D_1000029008. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 90.0 REMARK 200 PH : 8.35 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38745 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.6200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.80 REMARK 200 R MERGE FOR SHELL (I) : 0.30400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.680 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1IZN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 4000, 20% ISOPROPANOL, 20MM REMARK 280 EDTA, 0.1M TRIS-HCL, PH 8.35, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.71200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.51750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.50300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.51750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.71200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.50300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ORIGOMETRIC STATE OF THE ACTIN CAPPING PROTEIN IS A REMARK 300 HETERO DIMER COMPOSE OF SUBUNIT A (CHAIN A) AND SUBUNIT B (CHAIN B) REMARK 300 IN VIVO AND IN VITRO. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 PHE A 4 REMARK 465 GLU A 5 REMARK 465 ASP A 6 REMARK 465 ARG A 7 REMARK 465 VAL A 8 REMARK 465 SER A 276 REMARK 465 TYR A 277 REMARK 465 LYS A 278 REMARK 465 ILE A 279 REMARK 465 GLY A 280 REMARK 465 LYS A 281 REMARK 465 GLU A 282 REMARK 465 MET A 283 REMARK 465 GLN A 284 REMARK 465 ASN A 285 REMARK 465 ALA A 286 REMARK 465 MET B 1 REMARK 465 ASN B 252 REMARK 465 GLN B 253 REMARK 465 LYS B 254 REMARK 465 TYR B 255 REMARK 465 LYS B 256 REMARK 465 GLN B 257 REMARK 465 LEU B 258 REMARK 465 GLN B 259 REMARK 465 ARG B 260 REMARK 465 GLU B 261 REMARK 465 LEU B 262 REMARK 465 SER B 263 REMARK 465 GLN B 264 REMARK 465 VAL B 265 REMARK 465 LEU B 266 REMARK 465 THR B 267 REMARK 465 GLN B 268 REMARK 465 ARG B 269 REMARK 465 GLN B 270 REMARK 465 ILE B 271 REMARK 465 TYR B 272 REMARK 465 ILE B 273 REMARK 465 GLN B 274 REMARK 465 PRO B 275 REMARK 465 ASP B 276 REMARK 465 ASN B 277 REMARK 465 GLY C -4 REMARK 465 PRO C -3 REMARK 465 LEU C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 72 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 72 -155.44 -77.58 REMARK 500 SER A 115 26.52 -60.11 REMARK 500 TYR A 199 33.24 -143.73 REMARK 500 SER A 219 -110.15 -127.19 REMARK 500 THR A 253 -58.06 -126.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA B 1002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IZN RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN APO-FORM REMARK 900 RELATED ID: 3AA0 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH THE 21 AA LENGTH CARMIL FRAGMENT REMARK 900 RELATED ID: 3AA1 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH THE 23 AA LENGTH CKIP-1 FRAGMENT REMARK 900 RELATED ID: 3AA6 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH THE 23 AA LENGTH CD2AP FRAGMENT REMARK 900 RELATED ID: 3AA7 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN APO-FORM REMARK 900 RELATED ID: 3AAE RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEXED WITH THE 32 AA LENGTH CARMIL FRAGMENT DBREF 3AAA A 1 286 UNP P13127 CAZA1_CHICK 1 286 DBREF 3AAA B 1 277 UNP P14315 CAPZB_CHICK 1 277 DBREF 3AAA C 1 118 UNP P58546 MTPN_HUMAN 1 118 SEQADV 3AAA GLY C -4 UNP P58546 EXPRESSION TAG SEQADV 3AAA PRO C -3 UNP P58546 EXPRESSION TAG SEQADV 3AAA LEU C -2 UNP P58546 EXPRESSION TAG SEQADV 3AAA GLY C -1 UNP P58546 EXPRESSION TAG SEQADV 3AAA SER C 0 UNP P58546 EXPRESSION TAG SEQRES 1 A 286 MET ALA ASP PHE GLU ASP ARG VAL SER ASP GLU GLU LYS SEQRES 2 A 286 VAL ARG ILE ALA ALA LYS PHE ILE THR HIS ALA PRO PRO SEQRES 3 A 286 GLY GLU PHE ASN GLU VAL PHE ASN ASP VAL ARG LEU LEU SEQRES 4 A 286 LEU ASN ASN ASP ASN LEU LEU ARG GLU GLY ALA ALA HIS SEQRES 5 A 286 ALA PHE ALA GLN TYR ASN MET ASP GLN PHE THR PRO VAL SEQRES 6 A 286 LYS ILE GLU GLY TYR ASP ASP GLN VAL LEU ILE THR GLU SEQRES 7 A 286 HIS GLY ASP LEU GLY ASN GLY ARG PHE LEU ASP PRO ARG SEQRES 8 A 286 ASN LYS ILE SER PHE LYS PHE ASP HIS LEU ARG LYS GLU SEQRES 9 A 286 ALA SER ASP PRO GLN PRO GLU ASP THR GLU SER ALA LEU SEQRES 10 A 286 LYS GLN TRP ARG ASP ALA CYS ASP SER ALA LEU ARG ALA SEQRES 11 A 286 TYR VAL LYS ASP HIS TYR PRO ASN GLY PHE CYS THR VAL SEQRES 12 A 286 TYR GLY LYS SER ILE ASP GLY GLN GLN THR ILE ILE ALA SEQRES 13 A 286 CYS ILE GLU SER HIS GLN PHE GLN PRO LYS ASN PHE TRP SEQRES 14 A 286 ASN GLY ARG TRP ARG SER GLU TRP LYS PHE THR ILE THR SEQRES 15 A 286 PRO PRO THR ALA GLN VAL ALA ALA VAL LEU LYS ILE GLN SEQRES 16 A 286 VAL HIS TYR TYR GLU ASP GLY ASN VAL GLN LEU VAL SER SEQRES 17 A 286 HIS LYS ASP ILE GLN ASP SER VAL GLN VAL SER SER ASP SEQRES 18 A 286 VAL GLN THR ALA LYS GLU PHE ILE LYS ILE ILE GLU ASN SEQRES 19 A 286 ALA GLU ASN GLU TYR GLN THR ALA ILE SER GLU ASN TYR SEQRES 20 A 286 GLN THR MET SER ASP THR THR PHE LYS ALA LEU ARG ARG SEQRES 21 A 286 GLN LEU PRO VAL THR ARG THR LYS ILE ASP TRP ASN LYS SEQRES 22 A 286 ILE LEU SER TYR LYS ILE GLY LYS GLU MET GLN ASN ALA SEQRES 1 B 277 MET SER ASP GLN GLN LEU ASP CYS ALA LEU ASP LEU MET SEQRES 2 B 277 ARG ARG LEU PRO PRO GLN GLN ILE GLU LYS ASN LEU SER SEQRES 3 B 277 ASP LEU ILE ASP LEU VAL PRO SER LEU CYS GLU ASP LEU SEQRES 4 B 277 LEU SER SER VAL ASP GLN PRO LEU LYS ILE ALA ARG ASP SEQRES 5 B 277 LYS VAL VAL GLY LYS ASP TYR LEU LEU CYS ASP TYR ASN SEQRES 6 B 277 ARG ASP GLY ASP SER TYR ARG SER PRO TRP SER ASN LYS SEQRES 7 B 277 TYR ASP PRO PRO LEU GLU ASP GLY ALA MET PRO SER ALA SEQRES 8 B 277 ARG LEU ARG LYS LEU GLU VAL GLU ALA ASN ASN ALA PHE SEQRES 9 B 277 ASP GLN TYR ARG ASP LEU TYR PHE GLU GLY GLY VAL SER SEQRES 10 B 277 SER VAL TYR LEU TRP ASP LEU ASP HIS GLY PHE ALA GLY SEQRES 11 B 277 VAL ILE LEU ILE LYS LYS ALA GLY ASP GLY SER LYS LYS SEQRES 12 B 277 ILE LYS GLY CYS TRP ASP SER ILE HIS VAL VAL GLU VAL SEQRES 13 B 277 GLN GLU LYS SER SER GLY ARG THR ALA HIS TYR LYS LEU SEQRES 14 B 277 THR SER THR VAL MET LEU TRP LEU GLN THR ASN LYS THR SEQRES 15 B 277 GLY SER GLY THR MET ASN LEU GLY GLY SER LEU THR ARG SEQRES 16 B 277 GLN MET GLU LYS ASP GLU THR VAL SER ASP SER SER PRO SEQRES 17 B 277 HIS ILE ALA ASN ILE GLY ARG LEU VAL GLU ASP MET GLU SEQRES 18 B 277 ASN LYS ILE ARG SER THR LEU ASN GLU ILE TYR PHE GLY SEQRES 19 B 277 LYS THR LYS ASP ILE VAL ASN GLY LEU ARG SER ILE ASP SEQRES 20 B 277 ALA ILE PRO ASP ASN GLN LYS TYR LYS GLN LEU GLN ARG SEQRES 21 B 277 GLU LEU SER GLN VAL LEU THR GLN ARG GLN ILE TYR ILE SEQRES 22 B 277 GLN PRO ASP ASN SEQRES 1 C 123 GLY PRO LEU GLY SER MET CYS ASP LYS GLU PHE MET TRP SEQRES 2 C 123 ALA LEU LYS ASN GLY ASP LEU ASP GLU VAL LYS ASP TYR SEQRES 3 C 123 VAL ALA LYS GLY GLU ASP VAL ASN ARG THR LEU GLU GLY SEQRES 4 C 123 GLY ARG LYS PRO LEU HIS TYR ALA ALA ASP CYS GLY GLN SEQRES 5 C 123 LEU GLU ILE LEU GLU PHE LEU LEU LEU LYS GLY ALA ASP SEQRES 6 C 123 ILE ASN ALA PRO ASP LYS HIS HIS ILE THR PRO LEU LEU SEQRES 7 C 123 SER ALA VAL TYR GLU GLY HIS VAL SER CYS VAL LYS LEU SEQRES 8 C 123 LEU LEU SER LYS GLY ALA ASP LYS THR VAL LYS GLY PRO SEQRES 9 C 123 ASP GLY LEU THR ALA PHE GLU ALA THR ASP ASN GLN ALA SEQRES 10 C 123 ILE LYS ALA LEU LEU GLN HET IPA B1001 4 HET IPA B1002 4 HETNAM IPA ISOPROPYL ALCOHOL HETSYN IPA 2-PROPANOL FORMUL 4 IPA 2(C3 H8 O) FORMUL 6 HOH *354(H2 O) HELIX 1 1 SER A 9 HIS A 23 1 15 HELIX 2 2 GLU A 28 ASN A 41 1 14 HELIX 3 3 ASN A 42 ALA A 50 1 9 HELIX 4 4 ALA A 51 GLN A 61 1 11 HELIX 5 5 THR A 77 HIS A 79 5 3 HELIX 6 6 LEU A 117 TYR A 136 1 20 HELIX 7 7 PRO A 165 ASN A 167 5 3 HELIX 8 8 SER A 220 THR A 253 1 34 HELIX 9 9 THR A 253 ARG A 259 1 7 HELIX 10 10 ASP A 270 LEU A 275 1 6 HELIX 11 11 SER B 2 LEU B 16 1 15 HELIX 12 12 PRO B 17 GLN B 19 5 3 HELIX 13 13 GLN B 20 ASP B 30 1 11 HELIX 14 14 VAL B 32 SER B 34 5 3 HELIX 15 15 LEU B 35 VAL B 43 1 9 HELIX 16 16 CYS B 62 TYR B 64 5 3 HELIX 17 17 SER B 90 GLU B 113 1 24 HELIX 18 18 SER B 160 GLY B 162 5 3 HELIX 19 19 PRO B 208 GLY B 234 1 27 HELIX 20 20 GLY B 234 ARG B 244 1 11 HELIX 21 21 CYS C 2 ASN C 12 1 11 HELIX 22 22 ASP C 14 LYS C 24 1 11 HELIX 23 23 LYS C 37 CYS C 45 1 9 HELIX 24 24 GLN C 47 LEU C 56 1 10 HELIX 25 25 THR C 70 GLY C 79 1 10 HELIX 26 26 HIS C 80 LYS C 90 1 11 HELIX 27 27 THR C 103 THR C 108 1 6 HELIX 28 28 ASN C 110 GLN C 118 1 9 SHEET 1 A 2 THR A 63 VAL A 65 0 SHEET 2 A 2 VAL A 74 ILE A 76 -1 O ILE A 76 N THR A 63 SHEET 1 B 4 ASP A 81 GLY A 83 0 SHEET 2 B 4 ARG A 86 ASP A 89 -1 O ARG A 86 N LEU A 82 SHEET 3 B 4 ILE A 94 ASP A 99 -1 O ILE A 94 N ASP A 89 SHEET 4 B 4 GLU A 104 PRO A 110 -1 O SER A 106 N LYS A 97 SHEET 1 C10 GLY A 139 ILE A 148 0 SHEET 2 C10 GLN A 151 GLN A 164 -1 O ILE A 155 N TYR A 144 SHEET 3 C10 TRP A 169 THR A 182 -1 O PHE A 179 N ILE A 154 SHEET 4 C10 THR A 185 TYR A 198 -1 O ALA A 189 N LYS A 178 SHEET 5 C10 ASN A 203 GLN A 217 -1 O ASP A 214 N VAL A 188 SHEET 6 C10 GLY B 185 THR B 202 -1 O ASN B 188 N VAL A 207 SHEET 7 C10 THR B 164 LYS B 181 -1 N SER B 171 O ARG B 195 SHEET 8 C10 ILE B 144 LYS B 159 -1 N GLN B 157 O HIS B 166 SHEET 9 C10 GLY B 127 GLY B 138 -1 N PHE B 128 O VAL B 156 SHEET 10 C10 VAL B 116 LEU B 124 -1 N VAL B 116 O LYS B 135 SHEET 1 D 2 ILE B 49 ARG B 51 0 SHEET 2 D 2 ASP B 58 LEU B 60 -1 O TYR B 59 N ALA B 50 SHEET 1 E 3 ARG B 66 ASP B 67 0 SHEET 2 E 3 SER B 70 ARG B 72 -1 O SER B 70 N ASP B 67 SHEET 3 E 3 TYR B 79 ASP B 80 -1 O ASP B 80 N TYR B 71 CISPEP 1 PRO A 183 PRO A 184 0 11.06 CISPEP 2 ASP B 80 PRO B 81 0 -4.44 SITE 1 AC1 5 GLN A 213 ASN B 77 PRO B 89 ALA B 91 SITE 2 AC1 5 HOH B1029 SITE 1 AC2 5 ASP A 214 VAL A 216 HOH A 288 SER B 76 SITE 2 AC2 5 LYS B 78 CRYST1 71.424 87.006 121.035 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014001 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011493 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008262 0.00000